Article Details
Retrieved on: 2022-10-01 11:40:28
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Renaissance Technologies LLC now owns 149,700 shares of the biopharmaceutical company's stock valued at $400,000 after acquiring an additional 7,400 ...
Article found on: reporter.am
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here